Published in J Clin Immunol on November 01, 1985
Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment. Sleep (2010) 1.43
Th17 cells in autoimmune demyelinating disease. Semin Immunopathol (2010) 1.27
Transgenic mouse model for central nervous system demyelination. Mol Cell Biol (1991) 1.15
Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J Clin Invest (1987) 1.09
Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. J Clin Invest (1995) 1.01
Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis. Clin Exp Immunol (1987) 1.00
Interferon gamma in acute and subacute encephalitis. Br Med J (Clin Res Ed) (1988) 0.92
Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS One (2015) 0.87
Neonatal high pressure hydrocephalus is associated with elevation of pro-inflammatory cytokines IL-18 and IFNgamma in cerebrospinal fluid. Cerebrospinal Fluid Res (2008) 0.85
Immune modulating peptides for the treatment and suppression of multiple sclerosis. Clin Immunol (2012) 0.84
Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis. Clin Exp Immunol (1991) 0.81
Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients. J Clin Immunol (1999) 0.80
Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients. Clin Exp Immunol (1999) 0.80
Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results. J Neurol Neurosurg Psychiatry (1990) 0.79
Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update. West J Med (1992) 0.79
Species-dependent differences of embryonic stem cell-derived neural stem cells after Interferon gamma treatment. Front Cell Neurosci (2012) 0.76
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet (1987) 3.79
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology (1987) 3.11
Relapsing transverse myelitis. Neurology (1991) 2.65
Myelopathic neurosarcoidosis: diagnostic value of enhanced MRI. Neurology (1991) 2.06
Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol (1968) 1.75
Nuclear magnetic resonance imaging in multiple sclerosis. Ann Neurol (1983) 1.75
Hydrocephalus as a sequela of experimental myxovirus infections. Exp Mol Pathol (1969) 1.68
Diagnosis of rabies by immunofluorescence in trypsin-treated histologic sections. JAMA (1980) 1.67
Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol (1977) 1.58
Familial clustering of hepatitis B infection. N Engl J Med (1973) 1.56
Entry overload, emergency department overcrowding, and ambulance bypass. Emerg Med J (2003) 1.52
Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells. Arch Virol (1982) 1.50
Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med (1984) 1.50
Isolation of a Streptococcus mutans strain producing a novel bacteriocin. Infect Immun (1984) 1.48
Hepatitis B antigen and antibody in blood donors: an epidemiologic study. J Infect Dis (1973) 1.46
Enhancement of fluorescent antibody staining of viral antigens in formalin-fixed tissues by trypsin digestion. J Infect Dis (1979) 1.46
The complement system: its importance in the host response to viral infection. Microbiol Rev (1982) 1.44
Experimental subacute sclerosing panencephalitis in the hamster: correlation of age with chronic inclusion-cell encephalitis. J Infect Dis (1972) 1.41
The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (1999) 1.38
The effect of complement depletion on the course of Sindbis virus infection in mice. J Immunol (1978) 1.38
Systemic alpha-interferon therapy of multiple sclerosis. Neurology (1984) 1.35
Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med (1975) 1.28
Virus-induced hydrocephalus: development of aqueductal stenosis in hamsters after mumps infection. Science (1967) 1.24
A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology (1984) 1.24
The role of complement in viral infections. II. the clearance of Sindbis virus from the bloodstream and central nervous system of mice depleted of complement. J Infect Dis (1980) 1.23
Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler (2000) 1.23
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology (1994) 1.21
Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. J Virol (1984) 1.20
Phylogenetic analysis of partial sequences of elongation factor 1alpha identifies major groups of lice (Insecta: Phthiraptera). Mol Phylogenet Evol (2001) 1.20
The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus. J Immunol (1980) 1.20
Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. J Immunol (1981) 1.19
Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol (1984) 1.18
Progressive multifocal leukoencephalopathy and cytarabine. Remission with treatment. JAMA (1973) 1.17
Brain stem tumors of childhood and adolescence. Am J Dis Child (1970) 1.15
A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients. Mult Scler (2006) 1.15
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapy. Ann Neurol (1977) 1.10
Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol (1990) 1.10
United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center. Mult Scler (2001) 1.09
Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment. Ann Neurol (1983) 1.08
Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. A simplified method for demonstrating cerebrospinal fluid oligoclonal immunoglobulin bands. Neurology (1977) 1.08
Mouse cytomegalovirus: placental infection. J Infect Dis (1969) 1.07
The clinical and pathological spectrum of brain-stem vascular malformations. Long-term course stimulates multiple sclerosis. Arch Neurol (1980) 1.07
Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med (1970) 1.06
The pathogenesis of Sindbis virus infection in athymic nude mice. J Immunol (1979) 1.05
Experimental cholelithiasis in the rabbit induced by cholestanol feeding: effect of neomycin treatment on bile composition and gallstone formation. J Lipid Res (1968) 1.05
Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis. Arch Neurol (1986) 1.04
Comprehensive viral immunology of multiple sclerosis. III. Analysis of CSF antibodies by radioimmunoassay. Arch Neurol (1980) 1.04
Viral antibodies in cerebrospinal fluid of multiple sclerosis and control patients: comparison between radioimmunoassay and conventional techniques. J Clin Microbiol (1978) 1.04
Natural killer cells appear to play no role in the recovery of mice from Sindbis virus infection. Immunology (1981) 1.04
Role of complement in viral infections: participation of terminal complement components (C5 to C9) in recovery of mice from Sindbis virus infection. Infect Immun (1980) 1.04
Colonization of the human oral cavity by a strain of Streptococcus mutans. J Dent Res (1985) 1.02
Granular ependymitis. Occurrence in myxovirus infected rodents and prevalence in man. Am J Pathol (1972) 1.01
Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: comparison of in vitro activation by concanavalin a and myelin basic protein. Cell Immunol (1980) 0.98
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial. Neurology (1996) 0.98
CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch Neurol (1980) 0.98
The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. Mult Scler (1995) 0.98
Changes in plasma IgE levels during complicated and uncomplicated measles virus infections. J Allergy Clin Immunol (1985) 0.97
Guinea pig cytomegalovirus: transplacental transmission. Brief report. Arch Virol (1979) 0.96
Competitive properties of lactate dehydrogenase mutants of the oral bacterium Streptococcus mutans in the rat. Arch Oral Biol (1982) 0.96
Subacute sclerosing panencephalitis (SSPE) agent in hamsters. I. Acute giant cell encephalitis in newborn animals. Exp Mol Pathol (1971) 0.95
Experimental subacute sclerosing panencephalitis: selective disappearance of measles virus matrix protein from the Central nervous system. J Infect Dis (1981) 0.95
A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways. Pediatr Res (2000) 0.95
Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology (1992) 0.94
Parallel evolution in the major haemoglobin genes of eight species of Andean waterfowl. Mol Ecol (2009) 0.94
Hepatitis B surface antigen in blood donors: further observations. J Infect Dis (1975) 0.94
Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production. Clin Immunol Immunopathol (1981) 0.94
Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity. Arch Virol (1986) 0.94
Experimental herpes simplex encephalitis. Treatment with pyrimidine nucleosides. Arch Neurol (1973) 0.93
Neural tube defects of chick embryos: an indirect result of influenza A virus infection. J Neuropathol Exp Neurol (1971) 0.92
Measles virus genome in infections of the central nervous system. J Infect Dis (1981) 0.92
Subacute sclerosing panencephalitis (SSPE) agent in hamsters. 3. Induction of defective measles infection in hamster brain. Exp Mol Pathol (1974) 0.92
Subacute sclerosing panencephalitis (SSPE) agent in hamsters. II. The neuropathology of acute and chronic infections. Exp Mol Pathol (1973) 0.91
Expression of five viral antigens in cells infected with wild-type and SSPE strains of measles virus: correlation with cytopathic effects and productivity of infections. Arch Virol (1982) 0.91
Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosis. Lancet (1980) 0.91
Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis. Ann Neurol (1990) 0.90
Sexual selection. Are ducks impressed by drakes' display? Nature (2001) 0.90
Giant vegetation due to Staphylococcus aureus endocarditis simulating left atrial myxoma. Am Heart J (1986) 0.90
Cerebrospinal fluid findings in asymptomatic patients with reactive serum fluorescent treponemal antibody absorption tests. Ann Neurol (1978) 0.90
Experimental subacute sclerosing panencephalitis in the hamster. Ultrastructure of the chronic disease. Lab Invest (1974) 0.90
Changes in serum C-reactive protein during complicated and uncomplicated measles virus infections. Infect Immun (1983) 0.90
Subacute sclerosing panencephalitis: remission after treatment with intraventricular interferon. Neurology (1986) 0.89
Temperature effects on lymphocyte transformation invitro. Immunol Commun (1977) 0.89
Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis. Infect Immun (1979) 0.88
Miniculture plaquing technique for mouse cytomegalovirus. Appl Microbiol (1971) 0.88
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up. J Interferon Res (1993) 0.88
Border disease: tissue culture studies of the virus in sheep. Am J Vet Res (1982) 0.88